Your healthcare provider may need to adjust other diabetes medications, such as increasing metformin doses, adding SGLT2 inhibitors or DPP-4 inhibitors, or adjusting insulin regimens
7 biggest news story of 2025: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), in widespread use to treat diabetes and obesity, have also demonstrated off-label benefits for a multitude of conditions, including cardiovascular disease, hypertension, Parkinsons, Alzheimers and some addictive disorders
Individual responses to astaxanthin may also differ depending on factors such as skin type, age, and overall health
Semaglutide GLP-1 may also help decrease cravings for high-calorie, unhealthy foods, supporting healthier eating habits
Its effectiveness rate exceeds 99%, meaning fewer than 1 in 100 women using Mirena will become pregnant within a year